• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

n-of-1临床试验:个体化医疗的终极策略?

The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?

作者信息

Lillie Elizabeth O, Patay Bradley, Diamant Joel, Issell Brian, Topol Eric J, Schork Nicholas J

机构信息

Scripps Health, La Jolla, CA 92037, USA.

出版信息

Per Med. 2011 Mar;8(2):161-173. doi: 10.2217/pme.11.7.

DOI:10.2217/pme.11.7
PMID:21695041
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3118090/
Abstract

N-of-1 or single subject clinical trials consider an individual patient as the sole unit of observation in a study investigating the efficacy or side-effect profiles of different interventions. The ultimate goal of an n-of-1 trial is to determine the optimal or best intervention for an individual patient using objective data-driven criteria. Such trials can leverage study design and statistical techniques associated with standard population-based clinical trials, including randomization, washout and crossover periods, as well as placebo controls. Despite their obvious appeal and wide use in educational settings, n-of-1 trials have been used sparingly in medical and general clinical settings. We briefly review the history, motivation and design of n-of-1 trials and emphasize the great utility of modern wireless medical monitoring devices in their execution. We ultimately argue that n-of-1 trials demand serious attention among the health research and clinical care communities given the contemporary focus on individualized medicine.

摘要

单病例临床试验将个体患者视为研究不同干预措施疗效或副作用特征时的唯一观察单位。单病例试验的最终目标是使用客观的数据驱动标准为个体患者确定最佳干预措施。此类试验可利用与基于标准人群的临床试验相关的研究设计和统计技术,包括随机化、洗脱期和交叉期,以及安慰剂对照。尽管单病例试验在教育环境中具有明显的吸引力且应用广泛,但在医学和一般临床环境中使用较少。我们简要回顾单病例试验的历史、动机和设计,并强调现代无线医疗监测设备在其实施过程中的巨大作用。鉴于当代对个性化医疗的关注,我们最终认为单病例试验应引起健康研究和临床护理界的高度重视。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d8/3118090/478946dc211e/nihms297482f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d8/3118090/478946dc211e/nihms297482f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d8/3118090/478946dc211e/nihms297482f1.jpg

相似文献

1
The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?n-of-1临床试验:个体化医疗的终极策略?
Per Med. 2011 Mar;8(2):161-173. doi: 10.2217/pme.11.7.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
4
Behavioural interventions for type 2 diabetes: an evidence-based analysis.2型糖尿病的行为干预:一项基于证据的分析。
Ont Health Technol Assess Ser. 2009;9(21):1-45. Epub 2009 Oct 1.
5
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
6
7
8
9
The N-of-1 Clinical Trial: A Timely Research Opportunity in Homeopathy.单病例临床试验:顺势疗法中一个适时的研究机会。
Homeopathy. 2018 Feb;107(1):10-18. doi: 10.1055/s-0037-1621731. Epub 2018 Jan 23.
10
Point-of-Care International Normalized Ratio (INR) Monitoring Devices for Patients on Long-term Oral Anticoagulation Therapy: An Evidence-Based Analysis.长期口服抗凝治疗患者的即时检测国际标准化比值(INR)监测设备:一项基于证据的分析。
Ont Health Technol Assess Ser. 2009;9(12):1-114. Epub 2009 Sep 1.

引用本文的文献

1
tDCS and Cognitive Training for Fatigued and Cognitively Impaired People with Multiple Sclerosis: An SCED Study.经颅直流电刺激与针对多发性硬化症疲劳及认知障碍患者的认知训练:一项单病例系列实验性设计研究
Brain Sci. 2025 Jul 28;15(8):807. doi: 10.3390/brainsci15080807.
2
Refining treatment strategies for non-small cell lung cancer lacking actionable mutations: insights from multi-omics studies.完善缺乏可靶向突变的非小细胞肺癌的治疗策略:多组学研究的见解
Br J Cancer. 2025 Aug 23. doi: 10.1038/s41416-025-03139-6.
3
Graph Representation Learning for the Prediction of Medication Usage in the UK Biobank Based on Pharmacogenetic Variants.基于药物遗传变异的英国生物银行中药物使用预测的图表示学习
Bioengineering (Basel). 2025 May 31;12(6):595. doi: 10.3390/bioengineering12060595.
4
Blueprint for clinical N-of-1 strategies with off-label precision treatments in monogenic epilepsies.单基因癫痫中应用超说明书精准治疗的临床单病例N-of-1策略蓝图。
Orphanet J Rare Dis. 2025 Jun 16;20(1):309. doi: 10.1186/s13023-025-03750-z.
5
From precision interventions to precision health.从精准干预到精准健康。
Nat Commun. 2025 May 30;16(1):5024. doi: 10.1038/s41467-025-60395-z.
6
Digital Biomarkers and AI for Remote Monitoring of Fatigue Progression in Neurological Disorders: Bridging Mechanisms to Clinical Applications.用于神经疾病疲劳进展远程监测的数字生物标志物与人工智能:连接机制与临床应用
Brain Sci. 2025 May 21;15(5):533. doi: 10.3390/brainsci15050533.
7
Albuminuria Responses to Dapagliflozin in Patients With Type 2 Diabetes: A Crossover Trial.达格列净治疗2型糖尿病患者蛋白尿的反应:一项交叉试验
JAMA Netw Open. 2025 Mar 3;8(3):e251689. doi: 10.1001/jamanetworkopen.2025.1689.
8
Experience sampling method studies in physical activity research: the relevance of causal reasoning.体育活动研究中的经验取样法研究:因果推理的相关性
Int J Behav Nutr Phys Act. 2025 Mar 5;22(1):28. doi: 10.1186/s12966-025-01723-w.
9
Bacteriophage therapy for multidrug-resistant infections: current technologies and therapeutic approaches.用于多重耐药感染的噬菌体疗法:当前技术与治疗方法
J Clin Invest. 2025 Mar 3;135(5):e187996. doi: 10.1172/JCI187996.
10
A review of concurrent sonified biofeedback in balance and gait training.平衡与步态训练中同步听觉生物反馈的综述。
J Neuroeng Rehabil. 2025 Feb 26;22(1):38. doi: 10.1186/s12984-025-01565-4.

本文引用的文献

1
Individual (N-of-1) trials can be combined to give population comparative treatment effect estimates: methodologic considerations.个体(n-of-1)试验可以合并以给出人群比较治疗效果估计:方法学考虑。
J Clin Epidemiol. 2010 Dec;63(12):1312-23. doi: 10.1016/j.jclinepi.2010.04.020. Epub 2010 Sep 22.
2
Clinical trials and rare diseases.临床试验与罕见病。
Adv Exp Med Biol. 2010;686:173-90. doi: 10.1007/978-90-481-9485-8_11.
3
Pharmacy benefit managers, pharmacies, and pharmacogenomic testing: prescription for progress?医药福利管理机构、药店和药物基因组学检测:进步的处方?
Sci Transl Med. 2010 Aug 11;2(44):44cm22. doi: 10.1126/scitranslmed.3001067.
4
The path to personalized medicine.个性化医疗之路。
N Engl J Med. 2010 Jul 22;363(4):301-4. doi: 10.1056/NEJMp1006304. Epub 2010 Jun 15.
5
Using science to improve the nation's health system: NIH's commitment to comparative effectiveness research.利用科学改善国家卫生系统:美国国立卫生研究院对比较效果研究的承诺。
JAMA. 2010 Jun 2;303(21):2182-3. doi: 10.1001/jama.2010.726.
6
Using N-of-1 trials to improve patient management and save costs.使用 N-of-1 试验改善患者管理并节省成本。
J Gen Intern Med. 2010 Sep;25(9):906-13. doi: 10.1007/s11606-010-1352-7. Epub 2010 Apr 13.
7
Transforming medicine via digital innovation.通过数字创新改变医学。
Sci Transl Med. 2010 Jan 27;2(16):16cm4. doi: 10.1126/scitranslmed.3000484.
8
Circulating nucleic acids as a potential source for cancer biomarkers.循环核酸作为癌症生物标志物的潜在来源。
Curr Mol Med. 2010 Mar;10(2):142-65. doi: 10.2174/156652410790963295.
9
Research agenda. Opportunities for research and NIH.研究议程。研究机会与美国国立卫生研究院。
Science. 2010 Jan 1;327(5961):36-7. doi: 10.1126/science.1185055.
10
Genomic and personalized medicine: foundations and applications.基因组学与个性化医学:基础与应用
Transl Res. 2009 Dec;154(6):277-87. doi: 10.1016/j.trsl.2009.09.005. Epub 2009 Oct 1.